128 related articles for article (PubMed ID: 8601331)
1. The relationship of thyrotropin receptor antibody levels to the severity of thyroid orbitopathy.
Shokeir MO; Pudek MR; Katz S; Rootman J; Kendler DL
Clin Biochem; 1996 Apr; 29(2):187-9. PubMed ID: 8601331
[No Abstract] [Full Text] [Related]
2. Thyroid-stimulating hormone receptor antibody assays: recommendation for correct interpretation of results in Graves disease.
Massart C; d'Herbomez M
Clin Chem; 2013 May; 59(5):855. PubMed ID: 23396139
[No Abstract] [Full Text] [Related]
3. Sensitivity of assays for TSH-receptor antibodies.
Bitcon V; Donnelly J; Kiaei D
J Endocrinol Invest; 2016 Oct; 39(10):1195-6. PubMed ID: 27531172
[No Abstract] [Full Text] [Related]
4. Current insights into animal models of Graves' disease and orbitopathy.
Wiesweg B; Johnson KT; Eckstein AK; Berchner-Pfannschmidt U
Horm Metab Res; 2013 Aug; 45(8):549-55. PubMed ID: 23613015
[TBL] [Abstract][Full Text] [Related]
5. Authors' reply.
Kahaly GJ; Diana T
J Endocrinol Invest; 2016 Oct; 39(10):1197-8. PubMed ID: 27531171
[No Abstract] [Full Text] [Related]
6. Pathogenesis of Graves' disease: molecular analysis of anti-thyrotropin receptor antibodies.
Akamizu T; Mori T; Nakao K
Endocr J; 1997 Oct; 44(5):633-46. PubMed ID: 9466318
[No Abstract] [Full Text] [Related]
7. Review of Mouse Models of Graves' Disease and Orbitopathy-Novel Treatment by Induction of Tolerance.
Ungerer M; Faßbender J; Li Z; Münch G; Holthoff HP
Clin Rev Allergy Immunol; 2017 Apr; 52(2):182-193. PubMed ID: 27368808
[TBL] [Abstract][Full Text] [Related]
8. Interaction of thyroid-stimulating antibody with Graves' thyroid-stimulating hormone-binding antibody.
Ochi Y; Kajita Y; Hamazu M; Nagata A
Horm Res; 2003; 59(5):222-8. PubMed ID: 12714785
[TBL] [Abstract][Full Text] [Related]
9. Thyroid-stimulating antibody is related to Graves' ophthalmopathy, but thyrotropin-binding inhibitor immunoglobulin is related to hyperthyroidism in patients with Graves' disease.
Noh JY; Hamada N; Inoue Y; Abe Y; Ito K; Ito K
Thyroid; 2000 Sep; 10(9):809-13. PubMed ID: 11041459
[TBL] [Abstract][Full Text] [Related]
10. Quantification of cells expressing the thyrotropin receptor in extraocular muscles in thyroid associated orbitopathy.
Boschi A; Daumerie Ch; Spiritus M; Beguin C; Senou M; Yuksel D; Duplicy M; Costagliola S; Ludgate M; Many MC
Br J Ophthalmol; 2005 Jun; 89(6):724-9. PubMed ID: 15923509
[TBL] [Abstract][Full Text] [Related]
11. Epitope mapping of tsh receptor-blocking antibodies in Graves' disease that appear during pregnancy.
Kung AW; Lau KS; Kohn LD
J Clin Endocrinol Metab; 2001 Aug; 86(8):3647-53. PubMed ID: 11502791
[TBL] [Abstract][Full Text] [Related]
12. Graves' ophthalmopathy: pathogenesis and clinical implications.
Major BJ; Busuttil BE; Frauman AG
Aust N Z J Med; 1998 Feb; 28(1):39-45. PubMed ID: 9544385
[No Abstract] [Full Text] [Related]
13. Comparison of new different assay systems for thyrotropin receptor antibodies with reference to thyroid-stimulating antibodies and thyroid stimulation-blocking antibodies in Graves' disease.
Hirooka Y; Li C; Takagi J; Gotoh M; Habu S; Yasaka-Nomura T; Ishihara R; Nakasone Y; Nakamura R; Morikawa R; Otake K; Nogimori T; Ishizuki Y
Int J Clin Pharmacol Res; 2004; 24(4):111-6. PubMed ID: 15754915
[TBL] [Abstract][Full Text] [Related]
14. Different genotypes of a functional polymorphism of the TSHR gene are associated with the development and severity of Graves' and Hashimoto's diseases.
Inoue N; Watanabe M; Katsumata Y; Hidaka Y; Iwatani Y
Tissue Antigens; 2013 Oct; 82(4):288-90. PubMed ID: 23962080
[No Abstract] [Full Text] [Related]
15. Hyperthyroid Graves' disease and primary hypothyroidism caused by TSH receptor antibodies in monozygotic twins: case reports.
Tani J; Yoshida K; Fukazawa H; Kiso Y; Sayama N; Mori K; Aizawa Y; Hori H; Nakasato N; Abe K
Endocr J; 1998 Feb; 45(1):117-21. PubMed ID: 9625455
[TBL] [Abstract][Full Text] [Related]
16. [Thyrotropin-binding inhibitory immunoglobulins G in thyroid gland cells in patients with Graves-Basedow disease. Clinical studies].
Nauman J; Faryna M; Kwiatkowska-Dutkiewicz E; Roszkowska K
Endokrynol Pol; 1986; 37(4):143-52. PubMed ID: 2881778
[No Abstract] [Full Text] [Related]
17. TSH-receptor antibodies in hypothyroid Graves' disease.
Konishi J; Kasagi K; Hidaka A; Takeuchi R; Iida Y; Nakamura H
Exp Clin Endocrinol; 1991 May; 97(2-3):303-7. PubMed ID: 1680728
[No Abstract] [Full Text] [Related]
18. Age May Influence the Impact of TRAbs on Thyroid Function and Relapse-Risk in Patients With Graves Disease.
Bano A; Gan E; Addison C; Narayanan K; Weaver JU; Tsatlidis V; Razvi S
J Clin Endocrinol Metab; 2019 May; 104(5):1378-1385. PubMed ID: 30517711
[TBL] [Abstract][Full Text] [Related]
19. [Thyrotropin-binding inhibitory immunoglobulins G in thyroid gland cells in patients with Graves-Basedow disease. II. Various methodologic aspects of their analysis].
Faryna M
Endokrynol Pol; 1986; 37(4):153-61. PubMed ID: 2881779
[No Abstract] [Full Text] [Related]
20. Immunoglobulins of untreated Graves' patients with or without thyrotropin receptor antibody (determined by porcine thyrocytes) universally elicit potent thyroid hormone-releasing activity in cultured human thyroid follicles.
Sato K; Yamazaki K; Yamada E; Kanaji Y; Miura M; Obara T
Thyroid; 1999 Oct; 9(10):979-88. PubMed ID: 10560951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
